No abstract available
Keywords:
HIV prevention; PrEP; antiretroviral agent; cost efficacy; extended release; long acting.
MeSH terms
-
Acquired Immunodeficiency Syndrome / drug therapy
-
Anti-HIV Agents / therapeutic use*
-
HIV Infections / drug therapy
-
Humans
-
Pre-Exposure Prophylaxis*
-
South Africa